Related by context. Frequent words. (Click for all words.) 65 oncology indications 64 Allovectin 7 R 64 veltuzumab 62 deforolimus 61 TOCOSOL Paclitaxel 60 ridaforolimus 60 MOZOBIL 60 Virulizin R 59 bafetinib 59 talactoferrin 59 Amrubicin 59 MAXY G# 59 BioWa 59 Icatibant 59 Pharmion Corporation 59 vernakalant oral 58 ophthalmic indications 58 CoTherix 58 voclosporin 58 registrational 58 AZX# 58 Orphan Drug status 58 hematological malignancies 58 Zelrix 57 ALN TTR# 57 Clavis Pharma 57 rNAPc2 57 Nexavar ® 57 fibrotic diseases 57 ophthalmic diseases 57 MONOVISC 57 immunologic diseases 57 Loramyc ® 57 Cinryze TM 57 KNS # 57 non alcoholic steatohepatitis 57 Orphan Drug designation 57 clofarabine 57 maribavir 57 Azixa 57 Aradigm Corporation 56 eniluracil 56 Asentar 56 orphan medicinal product 56 BENLYSTA 56 Orphan Drug 56 tamibarotene 56 ONSOLIS 56 commercializing therapeutic 56 Amigal 56 oncology therapeutics 56 SANCTURA R 56 Neuradiab 56 ocular diseases 56 nimotuzumab 56 MGCD# [001] 56 BEMA Buprenorphine 56 hematological cancers 56 ALN RSV# 56 immunotherapeutics 56 therapeutic monoclonal antibodies 55 FOLOTYN 55 NEUMUNE 55 Folotyn 55 Topical Interferon Alpha 2b 55 Genentech Roche 55 Cethrin 55 Hana Biosciences 55 small molecule therapeutics 55 PREOS 55 refractory Hodgkin lymphoma 55 hepatitis C HCV 55 Orphan Drug Designation 55 tanespimycin 55 Chemokine Therapeutics 55 Cloretazine R VNP#M 55 R bortezomib 55 Ceragenix 55 romidepsin 55 tesetaxel 55 confirmatory Phase III 55 humanized anti 55 Desmoteplase 55 Phase Ib 55 relapsed multiple myeloma 55 RNAi therapeutic 55 microRNA therapeutics 55 commercializes innovative biopharmaceuticals 55 methylnaltrexone 55 hematologic malignancies 55 belinostat 55 PROMACTA 55 L DOS# 55 Marqibo 55 DR Cysteamine 55 valopicitabine 55 ofatumumab 55 Chrysalin 55 Response Genetics Inc. 55 antisense drugs 55 Phase IIa clinical trials